Blocking Toxic Effects Could Make Clot-buster Safer
Monday, January 26, 2009 - 00:42
in Health & Medicine
The drug tPA (tissue-type plasminogen activator) can break up the blood clots that cause strokes and heart attacks, but it can also loosen the blood-brain barrier and generate inflammation in the brain. In mice, genetically removing LRP1, a receptor for tPA, from brain cells called microglia can soften tPA's harmful effects. Blocking LRP1 could make tPA safer.